Because DNA methylation in oocytes occurs in meiotically arrested cells[@R3],[@R7], it represents a uniquely informative system for investigating requirements and mechanisms of *de novo* methylation. These mechanisms, especially at CGIs, are poorly understood, mainly because of the very limited number of methylated CGIs identified so far in germ cells. To obtain genome-wide information on DNA methylation in oocytes, as well as in sperm, we performed Reduced Representation Bisulphite Sequencing (RRBS), using a protocol optimised for low amounts of DNA ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). RRBS combines the base-pair resolution and quantitative assessment of bisulphite sequencing with high enrichment for CGIs[@R8]-[@R9]. The fidelity of the method was demonstrated by detection of the expected methylation of known maternal germline differentially methylated regions (DMRs) at imprinted loci ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}).

CpG methylation overall, and in CGI and repetitive element contexts, showed a dynamic profile during oocyte growth: 0.5% of all CpGs assessed by RRBS were highly methylated in d5 oocytes (≥80% methylation), 11.3% in d20 germinal vesicle (GV) and 15.3% in ovulated metaphase II (MII) oocytes. CpG methylation was lower overall in mature oocytes than sperm (24.9% of CpGs highly methylated in sperm), consistent with previous observations on repetitive elements[@R10]; methylation in a CGI context, irrespective of location with respect to genes, was markedly lower in sperm ([Fig. 1a](#F1){ref-type="fig"}, Supplementary Fig. [3a-b](#SD1){ref-type="supplementary-material"} & [4](#SD1){ref-type="supplementary-material"}). Using a threshold for scoring CGIs that reads should cover ≥10% of the CpGs per CGI (see Methods for a full account), we obtained information on \~15,000 (\~65%) of the extended set of CGIs recently identified by CAP-Seq[@R11], and identified 1062 methylated CGIs (≥75% methylation) in mature oocytes ([Fig 1b-c](#F1){ref-type="fig"}; [Supplementary Table 1](#SD2){ref-type="supplementary-material"}). By extrapolation, there may be \~1600 fully methylated CGIs in mature oocytes. Of interest, we found that the CGIs associated with the major promoters of *Dnmt3b* and *Dnmt1* (*Dnmt1s*) were methylated ([Fig. 1d,e](#F1){ref-type="fig"}, [Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}). Eighty-nine CGIs identified as methylated in MII oocytes were not fully methylated in GV oocytes, demonstrating that CGIs acquire methylation at different rates during oocyte growth, as reported for germline DMRs[@R12]-[@R13] ([Supplementary Table 2](#SD1){ref-type="supplementary-material"}). In sperm, we identified 185 fully methylated CGIs, 58 of which were methylated exclusively in sperm and 100 were also methylated in mature oocytes (27 of the CGIs methylated in sperm were not informative in mature oocyte datasets) ([Fig 1b-c](#F1){ref-type="fig"}; [Supplementary Table 1](#SD2){ref-type="supplementary-material"}). For subsequent analyses, we considered CGIs scored with ≥75% methylation as fully methylated and those with ≤25% methylation as unmethylated; this does not exclude that CGIs scored between these cut-offs possess methylation.

Having identified the extent of CGI methylation in gametes, we tested whether they possessed distinctive sequence properties. In comparison with unmethylated CGIs, higher proportions of CGIs methylated in oocytes and sperm were intragenic ([Supplementary Fig 3a, 3c](#SD1){ref-type="supplementary-material"}), similar to findings of CGI methylation in somatic tissues[@R11],[@R14]-[@R15]. CGIs methylated in oocytes and sperm were shorter than unmethylated CGIs, with lower GC content and CpG density ([Supplementary Fig. 5a-d](#SD1){ref-type="supplementary-material"}). These properties may reflect the enrichment in intragenic CGIs, which are shorter and less CpG dense (data not shown), and this trend was also observed in comparing methylated intragenic and promoter CGIs ([Supplementary Fig. 5e](#SD1){ref-type="supplementary-material"}). Contrary to reports implicating tandem repeats in DMR methylation[@R16], the content of this repetitive element class was similarly low in germline methylated and unmethylated CGIs ([Supplementary Fig. 5f](#SD1){ref-type="supplementary-material"}). A systematic analysis of sequence properties performed using EpiGRAPH[@R17] identified sequence attributes enriched in methylated CGIs ([Supplementary Table 3](#SD1){ref-type="supplementary-material"}), but was not able to predict the methylation status of CGIs based on these. A key observation implicating intrinsic sequence properties in *de novo* methylation of DMRs is the tetrameric association of DNMT3A and DNMT3L, the factors responsible for DMR methylation[@R4]-[@R5],[@R18], which results in the two DNMT3A catalytic sites being separated by a spacing corresponding to 8-10bp of DNA. This spacing was described as the dominant CpG periodicity unit of maternal germline DMRs[@R6]. Importantly, we did not observe any differences in the CpG periodicity of CGIs methylated in oocytes or sperm, or unmethylated CGIs ([Supplementary Fig. 5g](#SD1){ref-type="supplementary-material"}). Overall, these results indicate that CGIs methylated in gametes do not appear to have strong discriminating sequence features.

We next examined whether CGIs methylated in oocytes depend on DNMT3A and DNMT3L, by performing RRBS on GV oocytes genetically depleted in these factors. Both *Dnmt3a*−/− and *Dnmt3L*−/− oocytes exhibited a gross, genome-wide reduction in CpG methylation, including at repetitive elements and CGIs independent of their genic location ([Fig. 2a](#F2){ref-type="fig"}, [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). Of 654 CGIs methylated in *Dnmt3a*+/+ oocytes with coverage in *Dnmt3a*−/− oocytes, the vast majority (96%) were unmethylated in *Dnmt3a*−/− oocytes ([Fig. 2b](#F2){ref-type="fig"}). We also had information on 301 methylated CGIs in *Dnmt3L*+/+ oocytes and their *Dnmt3L*−/− counterparts; similarly, 92% were unmethylated in *Dnmt3L*−/− oocytes ([Fig. 2c](#F2){ref-type="fig"}). Interestingly, the CGIs remaining methylated (≥75%) in *Dnmt3L*−/− oocytes were also highly methylated in *Dnmt3a*−/− oocytes, sperm and d5 oocytes, suggesting that they are incompletely demethylated during primordial germ cell reprogramming[@R19] ([Supplementary Table 1](#SD2){ref-type="supplementary-material"}). Overall, this demonstrates the genome-wide role of DNMT3A and DNMT3L in CGI methylation beyond genomic imprinting.

Recent reports highlight the link between active transcription and DNA methylation. We previously showed that transcription across the DMRs of the imprinted *Gnas* locus is required for their methylation in oocytes[@R12]. The H3K4 demethylase KDM1B, which is associated with active gene bodies, is required for methylation of a subset of DMRs in oocytes[@R20]-[@R21]. In addition, interaction of DNMT3A and DNMT3L with chromatin is inhibited by H3K4 methylation[@R22]-[@R23], whereas DNMT3A binds H3K36me3[@R24], a transcriptional elongation mark. To explore the general relationship between transcription and CGI methylation in oocytes, we undertook mRNA-Seq in d10 oocytes (onset of *de novo* methylation) ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}). This showed that methylated CGIs annotated as intragenic were more likely to be within transcription units active in oocytes compared to unmethylated intragenic CGIs (75% versus 28%, p\<0.001, χ^2^ test). Furthermore, methylated CGIs overlapping annotated promoters were more frequently within overlapping transcripts compared to unmethylated promoter CGIs (39% versus 8%, p\<0.001, χ^2^ test). In addition, mRNA-Seq identified alternative, upstream promoters for 35% of the methylated CGIs, versus 10% of unmethylated CGIs (p\<0.001, χ^2^ test) ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}). These observations strengthen an association between location within active transcription units and probability of methylation. We also performed H3K4me3 ChIP-Seq in d15 oocytes (early phase of *de novo* methylation) ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}). This revealed that CGIs methylated in oocytes were relatively depleted in H3K4me3: 6.4% of methylated CGIs had significant H3K4me3 enrichment compared with 60.9% of unmethylated CGIs (13% versus 65% for CGIs associated with annotated promoters, 2% versus 34% for intragenic CGIs and 4.5% versus 36% for intergenic CGIs) ([Fig. 2d](#F2){ref-type="fig"}; p\<0.001, Mann-Whitney U test). H3K4me3 enrichment at a large proportion of intra- and intergenic unmethylated CGIs has been described in other cell types, including ES cells[@R11].

Having identified a large set of methylated CGIs in mature oocytes, we asked what the biological role of such methylation is. The function of genes associated with methylated CGIs as assessed by gene ontology analysis is diverse (data not shown). To assess the impact of methylation on gene expression in oocytes, we compared expression in fully-grown GV oocytes with d10 growing oocytes by mRNA-Seq, but did not observe marked differences in expression levels of transcripts associated with methylated CGIs, including those with methylated promoter CGIs ([Fig. 3a](#F3){ref-type="fig"}). This suggests that most such transcripts accumulate during oocyte growth before the onset of methylation, or that these genes are transcribed from alternative, unmethylated promoters. Such alternative promoters may ensure stringent control of these genes by oocyte-specific factors or environment, and this control might also necessitate that their 'somatic' promoters are silenced. If CGI methylation does not contribute significantly to regulation of the maternal mRNA store in oocytes, it may nevertheless have important repercussions for expression of the associated genes post-fertilisation.

Following fertilisation, methylation is comprehensively reprogrammed (except for imprinted genes): the maternal genome is passively demethylated between the zygote and morula and the paternal genome actively in the zygote; this is followed by the establishment of new methylation landscapes[@R2]. To evaluate the significance of gamete-derived CGI methylation, we performed RRBS on blastocysts (E3.5). This was validated by the expected degree of methylation at twelve known maternal germline DMRs (range 45.2%-58.7%). Consistent with genome-wide erasure, there was a substantial reduction in the proportion of methylated CpGs (≥60%) across the genome or within CGIs compared with gametes ([Fig. 3b](#F3){ref-type="fig"}, [Supplementary Fig. 8a](#SD1){ref-type="supplementary-material"}). Crucially, a minority of CGIs methylated in germ cells showed complete protection from demethylation: only \~15% of CGIs methylated in oocytes retained ≥40% methylation in blastocysts ([Fig. 3b, c](#F3){ref-type="fig"}). This substantial post-fertilisation reprogramming suggests that most CGI methylation in oocytes and sperm is unrelated to imprinting, and argues that maintenance of methylation in preimplantation embryos is a decisive factor in imprinting.

However, we observed that most CGIs methylated in oocytes displayed greater levels of methylation in blastocysts than expected if they were fully subject to passive demethylation, by which methylation should be \<2% by the 32-cell stage. This was striking, as very few CGIs are methylated in blastocysts ([Fig. 3b, c](#F3){ref-type="fig"}, [Supplementary Fig 8b, c](#SD1){ref-type="supplementary-material"}). To examine the degree to which gametic methylation is a factor in CGI methylation in preimplantation embryos, we looked at the dependence of methylation in blastocysts on prior methylation in gametes. Of 280 CGIs displaying intermediate methylation levels (25-40%) in blastocysts, the vast majority (234; 83%; p\<0.001, χ^2^ test) were fully methylated in MII oocytes (including 27 CGIs methylated in both oocyte and sperm) ([Supplementary Fig. 8d](#SD1){ref-type="supplementary-material"}). In contrast, less than 0.5% of CGIs unmethylated in both gametes are methylated ≥25% in blastocysts ([Fig. 3c](#F3){ref-type="fig"}, [Supplementary Table 1](#SD2){ref-type="supplementary-material"}). To investigate whether CGI sequence influences the likelihood of maintaining methylation, we checked how the properties of CGIs highly methylated in MII oocytes (≥75%) differed according to methylation level in blastocysts. For most parameters the differences were minor, but there was a tendency for CGIs retaining higher levels of methylation to be shorter and to be intragenically located ([Supplementary Fig. 8e, f](#SD1){ref-type="supplementary-material"}). To validate CGI methylation allele-specifically, we examined a selection of CGIs in C57BL/6JxCast/Ei hybrid embryos by conventional bisulphite sequencing. As exemplified by the *Syt2* locus, the CGI is fully methylated in oocytes and the maternal allele partially retains methylation in blastocysts ([Fig. 3d](#F3){ref-type="fig"}, [Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}). For CGIs specifically methylated in sperm, there was less evidence for substantial maintenance of methylation in blastocysts ([Fig. 3c](#F3){ref-type="fig"}, [Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}). These findings extend observations of Borgel *et al*. who, from MeDIP-chip analysis of promoter methylation in preimplantation embryos, identified some non-imprinted sequences that resist demethylation in preimplantation development[@R25]. Thus, CGI methylation status in gametes strongly predisposes towards methylation in blastocysts, either by incomplete post-fertilisation demethylation of methylated CGIs, or because some legacy of gametic methylation instructs their re-methylation in a subpopulation of cells. By either mechanism, mosaicism of CGI methylation patterns between blastomeres is predicted to arise. This does not exclude a contribution of *de novo* methylation, as some CGIs unmethylated in gametes have become methylated in blastocysts ([Fig. 3c](#F3){ref-type="fig"}, [Supplementary Fig. 8d](#SD1){ref-type="supplementary-material"}, [Supplementary Table 1](#SD2){ref-type="supplementary-material"}), including genes involved in trophectoderm development[@R26].

In conclusion, we reveal the extent and dynamics of CGI methylation in oocytes; this provides an important reference by which to judge future studies on mechanisms of *de novo* methylation in germ cells. A comprehensive account of the differential CGI methylation in male and female gametes is also a prerequisite for defining the full repertoire of imprinted genes and the mechanistic basis of parent-of-origin expression effects in somatic tissues. We also describe an unexpectedly complex fate of gamete-derived methylation after fertilisation. Rather than a binary choice, with DMRs characterised by absolute maintenance and other gametic methylation comprehensively lost through active demethylation or lack of maintenance during the first cleavage divisions, our analysis suggests a greater diversity of methylation choices. This diversity might lead to the establishment of epigenetic mosaicism within the early embryo, which might have the potential to influence first lineage specification[@R27].

Methods {#S1}
=======

Samples {#S2}
-------

For methylation analysis, blastocysts (54) were collected from E3.5 and oocytes from 5 day (d5, 1883 oocytes), 20 day (GV, 3586 oocytes) and superovulated 4-5 week (MII, 443 oocytes) old C57BL/6J mice. *Dnmt3a*−/− GV oocytes (635) were obtained from crosses with ZP3-Cre transgenic males and *Dnmt3L*−/− GV oocytes (843) from DNMT3L-null homozygous females[@R18]; the corresponding control oocytes were collected from wild-type littermates (*Dnmt3a*+/+ 385 oocytes, *Dnmt3L*+/+ 809 oocytes). For allelic methylation studies, E3.5 blastocysts were collected from C57BL/6JxCAST/Ei hybrids. For mRNA-Seq, oocytes were collected from 10 day (644 d10 growing oocytes) and 35 day (913 fully grown GV oocytes) old C57BL/6J mice. For the H3K4me3 ChIP-Seq, 6400 d15 growing oocytes (CD1) were collected.

RRBS {#S3}
----

Genomic DNA was purified using the Qiaamp DNA Micro kit (Qiagen), followed by MspI digestion (Fermentas), end-repair/A-Tailing (Klenow exo-, Fermentas, dCTPs 1nM, dGTPs, 1nM, dATPs 10nM) and 5mC-adapter ligation (T4 Ligase, Fermentas) performed within the same tube and buffer (Tango 1X, Fermentas), by heat-inactivating each enzymatic step followed by adjustment with the reagents required for the next step. Then bisulphite conversion was performed (Imprint DNA Modification, Sigma) and converted DNA was amplified (6 cycles) using a uracil stalling free polymerase (Pfu Turbo Cx, Stratagene), followed by size selection (150-450bp, Qiagen) and second round amplification (10-13 cycles; Platinium Pfx polymerase, Invitrogen). Libraries were purified (SPRI beads, Agencourt) and sequenced on Illumina GA-IIx. Because of low complexity at the start of each sequence (MspI fragments) Bareback was performed (<http://www.bioinformatics.bbsrc.ac.uk/projects>). Sequence alignment and methylation calls were performed using Bismark[@R28]. CpGs with read depth \<5 were discarded. For every analysis, all informative CpGs were used. To score CGI methylation, the following cut-offs were applied. Methylation level was determined for CGIs with information on ≥10% of their total CpGs (with a minimum of 5CpGs), and by averaging individual cytosine methylation levels. CGIs with an average methylation level ≥75% and ≤25% were called methylated and unmethylated, respectively. The unmethylated CGIs group corresponds to CGIs called unmethylated in both oocytes and sperm. A false discovery rate (FDR) for CpG methylation was determined empirically from the calls observed for CpGs within 11 known DMRs and was maximally 0.0439% at the minimum level of observation of 5 reads. p values for all methylated CGIs, based on departure from genome-wide methylation levels, were \<0.05% (χ^2^ test with Bonferroni correction for multiple testing). CGIs with contradictory methylation assignments in replicate libraries were excluded from analysis.

mRNA-Seq {#S4}
--------

Total RNA was extracted (TriZOL, Invitrogen), mRNA purified using oligo-dT Dynabeads (Invitrogen) and fragmented (Ambion), followed by first strand (Superscript III, Invitrogen) and second strand (DNA Pol.I, NEB) synthesis and reaction purification (Minelute, Qiagen). One-step A-tailing and adapter ligation were performed as for RRBS, followed by size selection (250bp +/−25bp, Qiaquick, Qiagen) and library amplification (15cycles, Platinium Pfx polymerase, Invitrogen). Libraries were purified (SPRI beads, Agencourt) and sequenced on Illumina GA-IIx, either single-read for expression analysis or paired-end for gene structure prediction (d10 oocytes). Sequences were aligned using TopHat.

ChIP-Seq {#S5}
--------

H3K4me3 immunoprecipitation (39159, Active Motif) was performed as described elsewhere[@R29] with minor modifications. ChIP was performed in duplicate from 3200 oocytes. Illumina Libraries were generated (input and IP) using an NEBNext kit (Set 1, NEB), except that adapter ligation was performed as for RRBS. Sequences were aligned using an ungapped Eland alignment with default stringency parameters. Owing to high background results from the limited starting material, reads from duplicates were combined. Technical assessment was made by comparison with ES cell H3K4me3 ChIP-Seq datasets (GSM594581 and GSM535982)[@R11],[@R30].

Direct Bisulphite Sequencing {#S6}
----------------------------

DNA was purified by proteinase K digestion and phenol-chloroform extraction, spiked with Lambda DNA and bisulphite treated (Zymo). Each PCR comprised a minimum of 50 oocytes or 2-3 blastocyst equivalents. Cloning and analysis were performed as described elsewhere[@R31], with removal of clones with identical patterns of conversion. Primers used for the amplification of specific CGIs from bisulphite modified DNA are given in [Supplementary Table 4.2](#SD1){ref-type="supplementary-material"}.

Statistical analysis {#S7}
--------------------

For categorical data, such as distribution of CpGs or CGIs methylation, χ^2^ tests were applied. For quantitative data, Mann-Whitney U tests (between 2 groups) and Kruskall-Wallis tests (between more than 2 groups), were applied.

Additional information {#S8}
----------------------

Dataset analysis was based on build NCBIM37/mm9 of the mouse genome and performed using Seqmonk (<http://www.bioinformatics.bbsrc.ac.uk/projects>). Promoter CGIs were defined as overlapping an annotated TSS (EnsEMBL, Refseq or UCSC); intragenic CGIs as overlapping an annotated gene without its TSS; intergenic CGIs were not overlapping annotated genes or promoters. Promoters were defined as the region 2kb upstream of annotated TSS. For repetitive element analysis, positions of individual instances of LINE, SINE, tandem repeats, long terminal repeats (LTR) and low complexity regions (LCR) were extracted from EnsEMBL. The overlap between full length CGIs and individual repeat types was determined as percentage of the CGI length using a custom Perl script. CpG periodicity was determined as the distribution of inter-CpG distance (from C to C) between all pairs of CpGs in each region, averaged over all of the regions in a particular grouping.
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![DNA methylation landscape in oocytes and sperm determined by RRBS\
**a-b,** Distribution of CpG methylation levels across the genome (**a**, left), within CGIs (**a**, right), and CGI methylation (**b**), in immature (d5), mature (GV and MII) oocytes and sperm (\*\*\*: p\<0.001, χ^2^ test). The number of CpGs and CGIs analysed is indicated in [Suppl. Fig 1b](#SD1){ref-type="supplementary-material"}. **c,** Chromosome distribution of the 1062 CGIs methylated in oocytes and 185 CGIs methylated in sperm (100 CGIs in both). **d**, CpG methylation levels (percentage of all cytosines called methylated) at the *Dnmt3b* and *Dnmt1s* promoter CGIs in GV oocytes. The grey vertical lines represent the sequencing read depth of individual cytosines; below, percentage methylation of the corresponding CpGs is represented by coloured vertical lines.](ukmss-35520-f0001){#F1}

![Mechanism of DNA methylation establishment in oocytes\
**a,** Distribution of CpG methylation levels across the genome in *Dnmt3a*−/− and *Dnmt3L*−/− oocytes and their wild-type counterparts (+/+); the number of CpGs analysed is indicated in [Suppl. Fig 1b](#SD1){ref-type="supplementary-material"} (\*\*\*: p\<0.001, χ^2^ test). **b-c,** Methylation levels of CGIs in *Dnmt3a*−/− and *Dnmt3L*−/− oocytes; only those CGIs for which methylation was ≥75% in the corresponding wild-type oocytes are displayed. **d,** Overall correlation between H3K4me3 enrichment determined in d15 oocytes by ChIP-seq and methylation status of CGIs (all CGIs irrespective of genomic location; \*\*\*: p\<0.001, Mann-Whitney U test).](ukmss-35520-f0002){#F2}

![Biological significance and fate of CGI methylation in oocytes\
**a,** mRNA expression levels in d10 and GV oocytes of the genes associated with methylated CGIs, either promoter (red, n=410) or intragenic (blue, n=555). **b,** Methylation levels in blastocysts of the CGIs identified as methylated in mature oocytes; twelve known germline DMRs with informative coverage are displayed in red (range 45.2%-58.7%). **c,** Range of methylation in blastocysts of the CGIs methylated specifically in oocytes (n=803) or sperm (n=51), methylated in both oocytes and sperm (n=86) and unmethylated in gametes (n=11512). **d,** Bisulphite sequencing in GV oocytes, sperm and C57BL/6JxCAST/Ei hybrid E3.5 blastocysts of the *Syt2* CGI. Bisulphite sequence profiles from the maternal (mat) and paternal (pat) alleles in blastocysts were discriminated by polymorphisms between C57BL/6J and CAST/Ei. Open circles represent unmethylated CpGs and filled circles methylated CpGs.](ukmss-35520-f0003){#F3}
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